Castle biosciences announces first quarter 2020 results

Castle biosciences announces first quarter 2020 results.q1 revenue rose 100 percent to $17.4 million.q1 revenue estimate $13.8 million -- refinitiv ibes data.company suspends 2020 revenue guidance due to covid-19.during q1, business was not materially affected due to covid-19 situation.believes it has adequate access to reagents and consumables needed for testing patient samples.suspending its previously announced annual revenue guidance for 2020.
CSTL Ratings Summary
CSTL Quant Ranking